GGrantScoutHQCreate alert

Industry funding

Health & Biomedical grants — Page 2

Public health, clinical, biomedical, behavioral health and care-delivery funding. Results combine structured categories with topic evidence from the listing and may overlap with related industries.

580 current opportunities · showing 25–48

OPENResearch & Science

DoW Bone Marrow Failure, Resource Development Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Bone Marrow Failure Research Program (BMFRP) Resource Development Award (RDA) supports the development of a multiomic atlas generated from well-annotated human bone marrow failure (BMF) samples, with omic data derived from marrow specimens. The resulting dataset

Deadline
Nov 5, 2026
Funding
Estimated total program funding: $1,250,000
Check fit and official source →
OPENResearch & Science

DoW Reconstructive Transplant, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demon

Deadline
Nov 5, 2026
Funding
Estimated total program funding: $8,000,000
Check fit and official source →
OPENHealth & Medical

DoW Bone Marrow Failure, Idea Development Award

Defense Health Agency Contracting Activity - DHACA

Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. Distinctive Features:This funding opportunity is open to Establis

Deadline
Nov 5, 2026
Funding
Estimated total program funding: $4,000,000
Check fit and official source →
OPENResearch & Science

DoW Bone Marrow Failure, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical re

Deadline
Nov 5, 2026
Funding
Estimated total program funding: $1,250,000
Check fit and official source →
OPENResearch & Science

DoW Reconstructive Transplant, Concept Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Concept Award supports the exploration of highly innovative new concepts or untested theories that address an important problem relevant to reconstructive transplantation. The Concept Award does not support clinic

Deadline
Nov 5, 2026
Funding
Estimated total program funding: $600,000
Check fit and official source →
OPENEducation

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from t

Deadline
Nov 6, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

US Travelers Health Research, Surveillance, Communication, and Outreach Network

Centers for Disease Control and Prevention - ERA

The NOFO supports CDC"s efforts to protect U.S. residents traveling internationally. The goal is to help U.S. travelers with pre-travel preparation, access to timely health information while traveling, and timely research on health conditions. The project will:Improve access to high quality trav

Deadline
Nov 6, 2026
Funding
Estimated total program funding: $5,000,000
Check fit and official source →
OPENHealth & Medical

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

Centers for Disease Control and Prevention - ERA

The focus of this notice of funding opportunity (NOFO) is to produce insights into disease detection and prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers. Timely surveillance and sentinel detection are essential for colle

Deadline
Nov 6, 2026
Funding
Estimated total program funding: $30,000,000
Check fit and official source →
OPENResearch & Science

Purchase mid-range equipment for biomedical research: MRC Equip (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for

Deadline
Nov 6, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to el

Deadline
Nov 7, 2026
Funding
Estimated total program funding: $350,000
Check fit and official source →
OPENResearch & Science

DoW Parkinson’s, Early Investigator Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career

Deadline
Nov 7, 2026
Funding
Estimated total program funding: $4,200,000
Check fit and official source →
OPENHealth & Medical

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

National Institutes of Health

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-revi

Deadline
Nov 7, 2026
Funding
Estimated total program funding: $1,850,000
Check fit and official source →
OPENResearch & Science

DoW Parkinson’s, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Resea

Deadline
Nov 7, 2026
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENHealth & Medical

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

National Institutes of Health

This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and o

Deadline
Nov 10, 2026
Funding
Estimated total program funding: $6,300,000
Check fit and official source →
OPENHealth & Medical

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

National Institutes of Health

Applications for a 3-year extension/renewal of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) clinical trial consortium are requested to fully meet the enrollment targets, complete participant follow-up, and finalize data analysis and dissemination of study findings. This Notice of

Deadline
Nov 10, 2026
Funding
Estimated total program funding: $1,800,000
Check fit and official source →
OPENHealth & Medical

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,500,000
Check fit and official source →
OPENHealth & Medical

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for em

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENHealth & Medical

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrate

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $18,000,000
Check fit and official source →
OPENHealth & Medical

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular charact

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,900,000
Check fit and official source →
OPENHealth & Medical

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecim

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,100,000
Check fit and official source →
OPENHealth & Medical

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

National Institutes of Health

The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth s

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,000,000
Check fit and official source →
OPENHealth & Medical

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $40,000,000
Check fit and official source →
OPENSmall Business & Startups

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through thi

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,000,000
Check fit and official source →
OPENResearch & Science

Transformative sustainable AI technologies (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for

Deadline
Nov 11, 2026
Funding
See official notice
Check fit and official source →

Build a stronger shortlist

First confirm that your legal entity is an eligible applicant. Then check whether the proposed work, geography, award size and project period align with the current official notice. Industry relevance alone is not eligibility.